CAS RN: 330443-74-8
(3aR,8aS)-2-(pyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
Product Availability
Choose a grade to view its available package options.
7 package records5 with current stock2 grade groups
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20251212 |
100mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260111 |
10g |
Out of stock |
| | Inquiry |
| Batchno.20251014 |
1g |
In stock |
Shanghai | | Inquiry |
| Batchno.20250510 |
250mg |
In stock |
Shanghai | | Inquiry |
| Batchno.20260324 |
50mg |
In stock |
Shanghai, Shenzhen | | Inquiry |
| Batchno.20260105 |
5g |
In stock |
Shanghai | | Inquiry |
| Batch No. | Package | Availability | Warehouse | Lead Time | Inquiry |
| Batchno.20250713 |
50mg / 100mg / 250mg |
Out of stock |
| 8-10 business days | Inquiry |
-
Product code:
starshine_CAS330443-74-8
-
Purity/Analytical Methods:
>99.0%
GET A QUOTE
330443-74-8 / (3aS,8bR)-2-pyridin-2-yl-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazole
Standard CAS: 330443-74-8
Multi CAS: Yes
Basic Information
CAS
330443-74-8
Multi CAS
Yes
Molecular Formula
C15H12N2O
Molecular Weight
236.270000
Exact Mass
236.094963
InChI
InChI=1S/C15H12N2O/c1-2-6-11-10(5-1)9-13-14(11)17-15(18-13)12-7-3-4-8-16-12/h1-8,13-14H,9H2/t13-,14+/m0/s1
InChIKey
JPCAXHBKQLBOJG-UONOGXRCSA-N
Computed Properties
Structural Parameters
Heavy atom count
18
Aromatic heavy atom count
12
Fraction Csp3
0.2
Rotatable bonds
1
H-bond acceptors
3
Molar refractivity
68.53
TPSA
34.48
LogP / Solubility
WLOGP
2.52
MLOGP
2.23
XLogP3
2.5
Consensus LogP
2.42
Log S (ESOL)
-3.32
Class (ESOL)
Poorly soluble
Log S (Ali)
-3.32
Class (Ali)
Poorly soluble
Log S (SILICOS-IT)
-3.41
Class (SILICOS-IT)
Poorly soluble
ADME
GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-2.37
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
3